Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2020-001616-18-ES
EUCTR2020-001616-18-ES
Active, not recruiting
Phase 1

Treatment with inhaled corticoids in patients with COVID-19 admitted to hospital with pneumonia

Fundació Clinic per a la Recerca Biomèdica0 sites300 target enrollmentApril 20, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID19MedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]
DrugsPulmicort Turbuhaler 400 microgramos/inhalacion polvo para inhalacion

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
COVID19
Sponsor
Fundació Clinic per a la Recerca Biomèdica
Enrollment
300
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Fundació Clinic per a la Recerca Biomèdica

Eligibility Criteria

Inclusion Criteria

  • •2\.Age \>18 and \<80
  • •3\.Admitted for pneumonia (status \#3 and \#4 OMS scale)
  • •4\.Informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 250
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 50

Exclusion Criteria

  • •1\.Pregnancy
  • •2\.Contraindications for inhaled corticoids therapy
  • •3\.Participating in another intervention trial on COVID19
  • •4\. Current treatment with inhaled or systemic corticosteroids

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Early obstructive lung disease in Indian populatio
CTRI/2023/07/055792Dr Raja Dhar
Active, not recruiting
Phase 1
Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.Adult respiratory distress syndrome (ARDS) secondary to SARS-CoV-2Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2020-001307-16-ESFundación para la Investigación Biomédica Hospital Ramón y Cajal104
Active, not recruiting
Phase 1
Treating COVID-19 infections with inhaled corticosteroidsCOVID 19Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2020-001889-10-GBniversity of Oxford, Clinical Trials and Research Governance478
Recruiting
Phase 1
Effect of Corton on olfactory dysfunction in COVID-19 patients
IRCT20200522047542N1Mashhad University of Medical Sciences70
Recruiting
Not Applicable
Prospective study for efficacy of inhaled corticosteroid therapy with the use of fractional exhaled nitric oxide measurement in persistent and chronic cough.persistent and chronic cough
JPRN-UMIN000033673Yamanashi Prefectural Central Hospital40